GlaxoSmithKline plc
Explore GlaxoSmithKline
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
GlaxoSmithKline plc
Explore GlaxoSmithKline
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2025 Revenue
$41.5B
▲ 3.5% vs FY2024 ($40.1B)
Net Income: $6.6B
Source: Annual report / company filing
GlaxoSmithKline plc reported $41.5B in revenue for fiscal year 2025. This represents a growth of 3.5% compared to the 2024 figure of $40.1B.
Revenue climbed 3.5% to 41.5 billion, extending the post-Haleon pivot toward higher-margin Specialty Medicines and Vaccines as GSK funded market-access investment.
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.